Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what’s the best choice?

References

• Cho B, Roh JW, Park J, et al. Safety and effectiveness of dienogest (Visanne®) for treatment of endometriosis: a large prospective cohort study. Reprod Sci. 2020;27(3):905–915.
   PubMed Web of Science ®Google Scholar
• Porpora MG, Koninckx PR, Piazze J, et al. Correlation between endometriosis and pelvic pain. J Am Assoc Gynecol Laparosc. 1999;6(4):429–434.
   PubMedGoogle Scholar
• Giuliani M, Cosmi V, Pierleoni L, et al. Quality of life and sexual satisfaction in women suffering from endometriosis: an Italian preliminary study. Sexologies. 2016;25(1):e12–9–e19.
   Web of Science ®Google Scholar
• Rees M, Kiemle G, Slade P. Psychological variables and quality of life in women with endometriosis. J Psychosom Obstet Gynaecol. 2020;24:1–8. Epub ahead of print. PMID: 32706632.
   Google Scholar
• Cavaggioni G, Lia C, Resta S, et al. Are mood and anxiety disorders and alexithymia associated with endometriosis? A preliminary study. Biomed Res Int. 2014; 2014:1–5.
   Web of Science ®Google Scholar
• Laganà AS, La Rosa VL, Rapisarda A, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health. 2017; 9:323–330.
   PubMed Web of Science ®Google Scholar
• Luisi S, Pizzo A, Pinzauti S, et al. Neuroendocrine and stress-related aspects of endometriosis. Neuro Endocrinol Lett. 2015;36(1):15–23. PMID: 25789593.
   PubMed Web of Science ®Google Scholar
• Triantafyllidou O, Kolovos G, Voros C, et al. Time to full effect, following treatment with combined oral contraceptives (cyclic versus continuous administration) in patients with endometriosis after laparoscopic surgery: a prospective cohort study [published online ahead of print, 2020 Jan 24]. Hum Fertil (Camb). 2020;24:1–8.
   Google Scholar
• Muzii L, Di Tucci C, Achilli C, et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214(2):203–211.
   PubMed Web of Science ®Google Scholar
• Mita S, Shimizu Y, Sato A. Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β. Fertil Steril. 2014;101(2):595–601.
   PubMed Web of Science ®Google Scholar
• Choi J, Jo M, Lee E, et al. Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction. Mol Hum Reprod. 2020;26(1):30–39.
   PubMed Web of Science ®Google Scholar
• Murji A, Biberoğlu K, Leng J, et al. Use of dienogest in endometriosis: a narrative literature review and expert commentary. Curr Med Res Opin. 2020;36(5):895–907.
   PubMed Web of Science ®Google Scholar
• Moehner S, Becker K, Lange JA, et al. Risk of depression and anemia in users of hormonal endometriosis treatments: results from the VIPOS study. Eur J Obstet Gynecol Reprod Biol. 2020;251:212–217.
   PubMed Web of Science ®Google Scholar
• Jensen JT, Schlaff W, Gordon K. Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence. Fertil Steril. 2018;110(1):137–152.e1.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Buggio L, Berlanda N, et al. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016;106(7):1552–1571.e2.
   PubMed Web of Science ®Google Scholar
• Dragoman MV, Tepper NK, Fu R, et al. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet. 2018;141(3):287–294.
   PubMed Web of Science ®Google Scholar
• Dinger J. COCs containing dienogest and 30 µg ethinylestradiol may carry a higher VTE risk compared to corresponding preparations with levonorgestrel: a meta-analysis of four large cohort studies. Front Womens Health. 2020;5: 1–6.
   Google Scholar
• Katz J, Melzack R. Measurement of pain. Surg Clin North Am. 1999;79(2):231–252. PMID: 10352653.
   PubMed Web of Science ®Google Scholar
• Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171–1178.
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion [published correction appears in Fertil Steril. 2015 Aug;104(2):498]. Fertil Steril. 2014;101(4):927–935.
   PubMed Web of Science ®Google Scholar
• Römer T. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Arch Gynecol Obstet. 2018;298(4):747–753. Epub 2018 Aug 3. Erratum in: Arch Gynecol Obstet. 2019 Jan;299(1):293. PMID: 30076546.
   PubMed Web of Science ®Google Scholar
• Lee SR, Yi KW, Song JY, et al. Efficacy and safety of long-term use of dienogest in women with ovarian endometrioma. Reprod Sci. 2018; 25(3):341–346.
   PubMed Web of Science ®Google Scholar
• Maiorana A, Incandela D, Parazzini F, et al. Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience. Arch Gynecol Obstet. 2017;296(3):429–433.
   PubMed Web of Science ®Google Scholar
• Park SY, Kim SH, Chae HD, et al. Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months. Clin Exp Reprod Med. 2016;43(4):215–220.
   PubMedGoogle Scholar
• Mabrouk M, Paradisi R, Arena A, et al. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial. Gynecol Endocrinol. 2018;34(5):399–403.
   PubMed Web of Science ®Google Scholar
• García-Gómez E, Vázquez-Martínez ER, Reyes-Mayoral C, et al. Regulation of inflammation pathways and inflammasome by sex steroid hormones in endometriosis. Front Endocrinol (Lausanne). 2019;10:935.
   PubMed Web of Science ®Google Scholar
• Barra F, Scala C, Leone Roberti Maggiore U, et al. Long-term administration of dienogest for the treatment of pain and intestinal symptoms in patients with rectosigmoid endometriosis. JCM. 2020;9(1):154.
   Google Scholar
• Szubert M, Ziętara M, Suzin J. Conservative treatment of deep infiltrating endometriosis: review of existing options. Gynecol Endocrinol. 2018; 34(1):10–14.
   PubMed Web of Science ®Google Scholar
• Dando TM, Curran MP. Low-dose ethinylestradiol/levonorgestrel. Drugs. 2005;65(16):2299–2308.
   PubMedGoogle Scholar
• Marinho MCP, Magalhaes TF, Fernandes LFC, et al. Quality of life in women with endometriosis: an integrative review. J Womens Health (Larchmt). 2018;27(3):399–408.
   PubMed Web of Science ®Google Scholar
• Lang J, Yu Q, Zhang S, et al. Dienogest for treatment of endometriosis in chinese women: a placebo-controlled, randomized, double-blind phase 3 study. J Womens Health (Larchmt). 2018;27(2):148–155.
   PubMed Web of Science ®Google Scholar
• Techatraisak K, Hestiantoro A, Ruey S, et al. Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice. BMC Womens Health. 2019;19(1):68.
   PubMedGoogle Scholar
• Vercellini P, Donati A, Ottolini F, et al. A stepped-care approach to symptomatic endometriosis management: a participatory research initiative. Fertil Steril. 2018;109(6):1086–1096.
   PubMed Web of Science ®Google Scholar
• Angioni S, Pontis A, Malune ME, et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020;36(1):84–86.
   PubMed Web of Science ®Google Scholar